| Phase 09 trials |
|
Phase 0
|
NCT07435779 |
Feb 2026 → Feb 2027 expected |
— |
Hebei Senlang Biotechnology Inc., Ltd. |
Recruiting
|
No outcome recorded
|
|
Phase 0
|
NCT06681337 |
Nov 2024 → Dec 2025 overdue |
lupus nephritis |
Bioray Laboratories |
Not yet recruiting
|
No outcome recorded
|
|
Phase 0
|
NCT06680388 |
Nov 2024 → Dec 2027 expected |
autoimmune disease |
Institute of Hematology & Blood Diseases Hospital, China |
Recruiting
|
No outcome recorded
|
|
Phase 0
|
NCT04626765 |
Apr 2020 → Mar 2023 |
childhood acute lymphoblastic leukemia |
Hebei Senlang Biotechnology Inc., Ltd. |
Unknown
|
No outcome recorded
|
|
Phase 0
|
NCT04626726 |
Apr 2020 → May 2023 |
B-cell adult acute lymphocytic leukemia |
Hebei Senlang Biotechnology Inc., Ltd. |
Unknown
|
No outcome recorded
|
|
Phase 0
|
NCT04626739 |
Apr 2020 → Mar 2023 |
non-Hodgkin lymphoma |
Hebei Senlang Biotechnology Inc., Ltd. |
Unknown
|
No outcome recorded
|
|
Phase 0
|
NCT04169932 |
Nov 2019 → Nov 2022 |
B-cell non-Hodgkin lymphoma |
Shanghai Longyao Biotechnology Inc., Ltd. |
Unknown
|
No outcome recorded
|
|
Phase 0
|
NCT04184414 |
Jan 2018 → Jan 2020 |
B-cell acute lymphoblastic leukemia, follicular lymphoma, mantle cell lymphoma |
PersonGen BioTherapeutics (Suzhou) Co., Ltd. |
Unknown
|
No outcome recorded
|
|
Phase 0
|
NCT03407859 |
Jan 2016 → Dec 2024 |
therapy-related myeloid neoplasm |
Zhujiang Hospital |
Unknown
|
No outcome recorded
|
| Phase 14 trials |
|
Phase 1
|
NCT05585996 |
Aug 2022 → Nov 2025 |
B-cell non-Hodgkin lymphoma |
Second Affiliated Hospital, School of Medicine, Zhejiang University |
Unknown
|
No outcome recorded
|
|
Phase 1
|
NCT04012892 |
May 2019 → Apr 2021 |
non-Hodgkin lymphoma |
Chinese PLA General Hospital |
Unknown
|
No outcome recorded
|
|
Phase 1
|
NCT04012879 |
May 2019 → Apr 2021 |
acute lymphoblastic leukemia |
Chinese PLA General Hospital |
Unknown
|
No outcome recorded
|
|
Phase 1
|
NCT03559439 |
Apr 2018 → Nov 2021 |
B-cell acute lymphoblastic leukemia |
Shanghai Tong Ren Hospital |
Unknown
|
No outcome recorded
|
| Phase 1/24 trials |
|
Phase 1/2
|
NCT03232619 |
Aug 2018 → May 2020 |
acute leukemia |
Bioray Laboratories |
Completed
|
No outcome recorded
|
|
Phase 1/2
|
NCT03263208 |
Aug 2017 → Jan 2019 |
B-cell acute lymphoblastic leukemia |
Henan Cancer Hospital |
Unknown
|
No outcome recorded
|
|
Phase 1/2
|
NCT03146533 |
May 2017 → Apr 2019 |
B-cell neoplasm |
Shenzhen Second People's Hospital |
Unknown
|
No outcome recorded
|
|
Phase 1/2
|
NCT02134262 |
May 2014 → Mar 2017 |
B-cell non-Hodgkin lymphoma |
Jichi Medical University |
Unknown
|
No outcome recorded
|
| Phase not applicable7 trials |
| — |
NCT06993493 |
Feb 2025 → Aug 2027 expected |
autoimmune disease |
Beijing Boren Hospital |
Recruiting
|
No outcome recorded
|
| — |
NCT06983964 |
Feb 2025 → Feb 2027 expected |
autoimmune disease |
Beijing Boren Hospital |
Recruiting
|
No outcome recorded
|
| — |
NCT05618041 |
Sep 2022 → Sep 2027 expected |
acute lymphoblastic leukemia, plasma cell myeloma |
Hebei Senlang Biotechnology Inc., Ltd. |
Recruiting
|
No outcome recorded
|
| — |
NCT04796441 |
Dec 2020 → Dec 2021 |
acute myeloid leukemia |
Hebei Senlang Biotechnology Inc., Ltd. |
Unknown
|
No outcome recorded
|
| — |
NCT04792593 |
Dec 2020 → Dec 2021 |
— |
Hebei Senlang Biotechnology Inc., Ltd. |
Unknown
|
No outcome recorded
|
| — |
NCT04546893 |
Sep 2020 → Sep 2022 |
— |
Hebei Senlang Biotechnology Inc., Ltd. |
Unknown
|
No outcome recorded
|
| — |
NCT02813837 |
Jun 2015 → Jan 2021 |
lymphoid leukemia, lymphoma |
Innovative Cellular Therapeutics Co., Ltd. |
Unknown
|
No outcome recorded
|